SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-033514
Filing Date
2024-03-19
Accepted
2024-03-19 16:22:19
Documents
1
Period of Report
2024-03-16

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3906
  Complete submission text file 0000950170-24-033514.txt   5387
Mailing Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Issuer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O DYNAVAX TECHNOLOGIES CORPORATION 2100 POWELL STREET, SUITE 1900 EMERYVILLE CA 94608
Business Address
Burgess Justin (Reporting) CIK: 0001812025 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34207 | Film No.: 24763598